In Depth
Research Roundup
Debbie Rigby rounds up the latest in research news Cardiovascular risk assessment in women: which women are suited for menopausal hormone therapy? Individual risk assessment for atherosclerotic cardiovascular disease is …
Pharmacy partnerships: how do you make them work?
A pharmacy partnership can be like a marriage, with hard work you can navigate the challenges and find the solutions, says John Thornett It is often said that partnerships are …
On top of the world
Paul Sinclair is the first Australian to lead the International Pharmaceutical Federation (FIP). He also retains a burning passion for pharmacy in Australia. He spoke to AJP editor Chris Brooker …
Bureaucracy framing its own pharmacy ‘policy’?
It’s 1984, and pharmacy is questioning the influence of the Pharmaceutical Benefits Remuneration Tribunal…and looking at the “new technology” of 8mm video The first Community Pharmacy Agreement – known as …
Fighting the clause
Should you consent to an order under Clause 175 of the Poisons and Therapeutic Goods Regulation? lawyer Maurice Hannan investigates In the wake of section 150 proceedings, the Pharmacy Council …
Research Roundup
Debbie Rigby rounds up the latest in research news Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA) Cough is the most common symptom leading to medical consultation. Chronic …
It’s 4 years since the first COVID case in Australia
Here’s how our pandemic experiences have changed over time, writes Deborah Lupton from UNSW Sydney It might be hard to believe, but four years have now passed since the first …
Research Roundup
Debbie Rigby takes a look at the latest in research news Cannabis for chronic pain: cardiovascular safety Analysis of nearly 2 million patients with chronic pain using Danish registers reveals …
Are discount models detrimental?
Melbourne pharmacist Pardeep Singh takes aim at the discount model, arguing it has negative impacts for patients and the profession I’m curious if anyone is aware of any ‘discount petrol …
Stepping over the line
Administration of Long Acting Injectable Buprenorphine injections by pharmacists has been a ‘quantum shift’ in the profession’s scope of practice Long Acting Injectable Buprenorphine (LAIB) has been a revolution in …
Hunting for unicorns
It’s the great quest of modern pharmacy, finding the pharmacist who is comfortable with, and enjoys, front-of-practice encounters. Do they exist? People have been hunting unicorns for millennia. The first …
PPIs: weighing up the good and the bad
Proton pump inhibitors (PPIs) are the cornerstone of management for many gastrointestinal disorders. However, their increasingly widespread use is raising significant concerns, says Jala Moushi Proton pump inhibitors (PPIs) are …